Cite
APA Citation
Lutz, J., Lazzaro, S., Habbeddine, M., Schmidt, K., Baumhof, P., Mui, B., Tam, Y., Madden, T., Hope, M., Heidenreich, R., & Fotin-Mleczek, M. (2017). unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. Npj vaccines, 2, 1–9. http://access.bl.uk/ark:/81055/vdc_100084801975.0x000069